P. Gerry Fegan

1.0k total citations · 1 hit paper
47 papers, 610 citations indexed

About

P. Gerry Fegan is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, P. Gerry Fegan has authored 47 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in P. Gerry Fegan's work include Diabetes Treatment and Management (20 papers), Diabetes Management and Research (14 papers) and Cardiovascular Function and Risk Factors (8 papers). P. Gerry Fegan is often cited by papers focused on Diabetes Treatment and Management (20 papers), Diabetes Management and Research (14 papers) and Cardiovascular Function and Risk Factors (8 papers). P. Gerry Fegan collaborates with scholars based in Australia, United Kingdom and Ireland. P. Gerry Fegan's co-authors include Bu B. Yeap, N. Lan, Girish Dwivedi, Angela C. Shore, Juliene Gonçalves Costa, Andrew Haynes, Louise H. Naylor, Gerald F. Watts, Daniel J. Green and Wendy A. Davis and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

P. Gerry Fegan

43 papers receiving 593 citations

Hit Papers

Incretin-Based Weight Loss Pharmacotherapy: Can Resistanc... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
    2024 59 citations P. Gerry Fegan, Bu B. Yeap et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Gerry Fegan Australia 13 338 130 105 104 76 47 610
Yaxin Lai China 14 584 1.7× 115 0.9× 95 0.9× 57 0.5× 78 1.0× 32 853
Alexandra K. Lee United States 18 411 1.2× 134 1.0× 86 0.8× 106 1.0× 88 1.2× 42 961
Lisa Swartz Topor United States 12 212 0.6× 42 0.3× 64 0.6× 122 1.2× 99 1.3× 56 537
Mark H. Schutta United States 18 463 1.4× 210 1.6× 223 2.1× 383 3.7× 152 2.0× 28 1.0k
Fabio Pannozzo Italy 9 101 0.3× 250 1.9× 75 0.7× 65 0.6× 46 0.6× 16 523
Hua-Fen Chen Taiwan 11 151 0.4× 61 0.5× 94 0.9× 83 0.8× 59 0.8× 15 385
Aodán Tynan Ireland 8 648 1.9× 109 0.8× 96 0.9× 87 0.8× 147 1.9× 8 917
Leonardo Mancillas‐Adame Mexico 10 246 0.7× 123 0.9× 153 1.5× 81 0.8× 59 0.8× 34 569
Mihail Zilbermint United States 16 513 1.5× 83 0.6× 78 0.7× 271 2.6× 129 1.7× 55 783
Silvia Perra Italy 13 125 0.4× 47 0.4× 174 1.7× 61 0.6× 76 1.0× 33 530

Countries citing papers authored by P. Gerry Fegan

Since Specialization
Citations

This map shows the geographic impact of P. Gerry Fegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gerry Fegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gerry Fegan more than expected).

Fields of papers citing papers by P. Gerry Fegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gerry Fegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gerry Fegan. The network helps show where P. Gerry Fegan may publish in the future.

Co-authorship network of co-authors of P. Gerry Fegan

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gerry Fegan. A scholar is included among the top collaborators of P. Gerry Fegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gerry Fegan. P. Gerry Fegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lan, N., Ivana Ferreira, Jens Carsten Ritter, et al.. (2025). The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes‐related foot ulceration. Physiological Reports. 13(11). e70415–e70415. 1 indexed citations
3.
Ihdayhid, Abdul Rahman, Matthew Erickson, James M. Rankin, et al.. (2024). Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome. Acta cardiologica. Supplementum. 79(2). 224–234.
4.
Lan, N., Ivana Ferreira, Jens Carsten Ritter, et al.. (2024). Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers. Diabetologia. 68(2). 460–470. 2 indexed citations
5.
Stewart, Jonathon, Juan Lü, Adrian Goudie, et al.. (2023). Western Australian medical students’ attitudes towards artificial intelligence in healthcare. PLoS ONE. 18(8). e0290642–e0290642. 40 indexed citations
6.
Fegan, P. Gerry, et al.. (2023). Three Cases of Non-islet Cell Tumor Hypoglycemia Highlighting Efficacy of Glucocorticoid Treatment. JCEM Case Reports. 1(4). luad045–luad045. 1 indexed citations
7.
8.
Lan, N., et al.. (2023). Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes. Primary care diabetes. 17(5). 526–528. 1 indexed citations
9.
Lan, N., et al.. (2022). Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes. Diabetes Research and Clinical Practice. 192. 110093–110093. 2 indexed citations
10.
11.
Lan, N., et al.. (2021). Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes. Journal of Diabetes and its Complications. 35(12). 108057–108057. 3 indexed citations
12.
Lan, N., et al.. (2020). Short-term outcomes following coronary artery bypass graft surgery in insulin treated and non-insulin treated diabetes: A tertiary hospital experience in Australia. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 455–458. 3 indexed citations
13.
Lan, N., et al.. (2020). Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes. International journal of cardiac imaging. 37(2). 517–527. 24 indexed citations
14.
Davis, Timothy M. E., et al.. (2019). Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia. Diabetes Technology & Therapeutics. 22(5). 367–373. 17 indexed citations
15.
Lan, N., P. Gerry Fegan, Bu B. Yeap, & Girish Dwivedi. (2019). The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Left Ventricular Function: Current Evidence and Future Directions. ESC Heart Failure. 6(5). 927–935. 61 indexed citations
16.
Alfonso, Helman, S. A. Paul Chubb, David J. Handelsman, et al.. (2017). Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men. Hormones and Cancer. 8(2). 119–126. 19 indexed citations
17.
Ong, Gregory S Y, et al.. (2010). Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma. European Journal of Endocrinology. 162(5). 1001–1008. 41 indexed citations
18.
Cheah, Chan Y., et al.. (2008). Mirtazapine associated with profound hyponatremia: Two case reports. ˜The œAmerican journal of geriatric pharmacotherapy. 6(2). 91–95. 10 indexed citations
19.
Fegan, P. Gerry, et al.. (2008). Prevalence and associations of psychological distress in young adults with Type 1 diabetes. Diabetic Medicine. 25(1). 91–96. 118 indexed citations
20.
Fegan, P. Gerry, et al.. (2005). Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid‐lowering therapy. Diabetic Medicine. 22(12). 1670–1676. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaxin Lai Breakdown of academic impact, for papers by Alexandra K. Lee Breakdown of academic impact, for papers by Lisa Swartz Topor Breakdown of academic impact, for papers by Mark H. Schutta Breakdown of academic impact, for papers by Fabio Pannozzo Breakdown of academic impact, for papers by Hua-Fen Chen Breakdown of academic impact, for papers by Aodán Tynan Breakdown of academic impact, for papers by Leonardo Mancillas‐Adame Breakdown of academic impact, for papers by Mihail Zilbermint Breakdown of academic impact, for papers by Silvia Perra
Rankless by CCL
2026